FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Summary

The purpose of this study is to investigate the safety and immunogenicity of the third vaccination with one of three different concentrations of a TBE vaccine in all volunteers who completed two vaccinations in one of the three treatment groups of Baxter study 205 (safety and immunogenicity of two vaccinations with FSME IMMUN NEW in healthy volunteers aged 6 to 16 years).

Timeline

Start

2002-02

Primary completion

—

Completion

2002-08

Drugs

Indications